drugset / Trial / NCT00365313

Preventing Recurrent Ulcer Bleeding in Arthritis Patients Using Esomeprazole Plus Celecoxib

NCT00365313

Phase 3 Completed 273 enrolled Chinese University of Hong Kong
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to compare the effect of Esomeparzole with Placebo in the Prevention of Recurrent Ulcer Bleeding in Patients Receiving a COX-2 Inhibitor

Timeline

Start
2002-08
Primary completion
Completion
2005-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Esomeprazole Small molecule 20 mg
Background Celecoxib Other / unclassified 200 mg